Mises à jour récentes
- Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD Animal ModelsAce Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies. Imaging techniques play a crucial role in studying...0 Commentaires 0 Parts 28 VueConnectez-vous pour aimer, partager et commenter!
- Ace Therapeutics Unveils Kidney Disease Preclinical Solutions to Power Up Renal Drug DevelopmentAce Therapeutics, a leading preclinical research organization, unveils its specialized nephrology-focused preclinical solutions to accelerate kidney disease drug development. With a comprehensive suite of validated models and cutting-edge technologies, Ace Therapeutics empowers researchers and biopharma companies to overcome challenges in renal drug discovery and translation. Kidney disease...0 Commentaires 0 Parts 88 Vue
- Ace Therapeutics Unveils Custom Disease Models to Power Up Ophthalmology ResearchAce Therapeutics announced the launch of its custom ocular modeling services, designed to accelerate advancements in ophthalmology research and enhance the discovery of therapeutic interventions. This groundbreaking service provides researchers with tailored models that closely mimic human ocular conditions, enabling more reliable results in preclinical studies. As ophthalmological...0 Commentaires 0 Parts 1987 Vue
- Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior TestsAce Therapeutics, a preclinical CRO in psychiatry dedicated to offering comprehensive one-stop services, released the expansion of its research capabilities in the area of depression through the introduction of comprehensive depression-related behavior tests in its preclinical investigation processes. This integral development aims to enhance the understanding of depressive disorders and...0 Commentaires 0 Parts 1768 Vue
- Custom Disease Models in Preclinical GI and Hepatology ResearchWith a commitment to advancing new drug development for liver and gastrointestinal (GI) diseases, Ace Therapeutics proudly announces the launch of its custom disease model development services, which come with a complete range of research services from target discovery to predictive efficacy testing. This strategic addition to Ace Therapeutics’ portfolio not only enhances its service...0 Commentaires 0 Parts 3971 Vue
- Gene Therapy Development to Unleash Glaucoma Drug ResearchAce Therapeutics is excited to announce the launch of its groundbreaking glaucoma gene therapy development services. This new initiative is set to advance research in glaucoma treatments, offering comprehensive support and innovation for researchers and pharmaceutical companies aiming to cure this pervasive eye disease. Glaucoma is a group of eye conditions that damage the optic nerve,...0 Commentaires 0 Parts 2684 Vue
Plus de lecture